Article Details
Retrieved on: 2021-09-24 10:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Octarine Bio, a synthetic biology company based in Copenhagen, will soon bring its biosynthetic psilocybin into human clinical trials through a new ...
Article found on: www.forbes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here